Caremark shareholders urged to vote for CVS bid

Caremark Rx Inc. shareholders should vote for CVS Corp.’s offer to buy the company for $26 billion, rejecting a rival bid from Express Scripts Inc., Institutional Shareholder Services Inc. said.

The recommendation is a change for the investor advisor firm. It said last month that Caremark shareholders should vote against the acquisition. CVS shareholders are scheduled to vote on the sale Thursday and Caremark investors are scheduled to vote the next day.